Higher-spending hospitals have fewer deaths for emergency patients

 

Vanderbilt study provides warning against spending cuts for certain patient populations

 

Nashville, TN, USA (April 3, 2012) – Higher-spending hospitals do have better outcomes for their emergency patients, including fewer deaths, according to a Vanderbilt study released as a working paper through the National Bureau of Economic Research.

 

Vanderbilt’s John Graves, Ph.D., assistant professor of Preventive Medicine, along with colleagues from the Massachusetts Institute of Technology and Cornell University, examined Medicare ambulance and hospital data from 2002-2008, finding that higher-cost hospitals have significantly lower one-year mortality rates compared to lower-cost hospitals.

 

"At least for emergency, acute patients in our study, overall mortality was reduced 20 to 30 percent in higher spending hospitals," Graves said.

 

"Doing more in the hospital, including being treated in a teaching or high technology hospital has a positive impact on outcomes. We found that right up front."

 

Treatment in a teaching hospital reduced the risk of death within 1 year by 4 percent, while the most technologically advanced hospitals conferred a 4.7 percent risk reduction. High levels of initial treatment intensity in emergency situations conferred the most protection, reducing risk by 18 percent

 

The researchers were then able to replicate their initial finding using additional data from New York State that matched exact patient addresses to hospital discharge records. There, they found that patients who live very near each other but on either side of ambulance-dispatch boundaries go to different types of hospitals and receive different levels of care.

 

The research runs counter to current thinking, which suggests hospitals that spend the most on Medicare patients have no better outcomes and no better patient satisfaction than hospitals that spend less, or even much less.

 

Some researchers have suggested that Medicare costs nationwide could be reduced 20 to 30 percent, without harming quality of care.

 

Graves said his study doesn’t discount the idea there is wasteful spending, but it does provide evidence that some hospitals spending more on acute or emergent care can have better survival outcomes.

 

The idea makes intuitive sense, but teasing out the complexities of cost versus quality has been difficult and some influential research in the last decade has failed to find benefits for spending more.

 

"An inefficient hospital, a high acuity hospital, and a technologically advanced hospital all will exhibit high cost structures, and each may or may not be better at saving lives," Graves said. "The challenge is being able to ‚unbundle‘ the complex cost-mortality association and pinpoint areas that can be improved upon to lower costs without harming quality."

 

Graves said the paper is important because it shows a creative approach can remove major barriers to more accurate cost-effectiveness research

 

 


Vanderbilt University Medical Center, 03.04.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…